These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37016465)

  • 21. The Diagnostic Capacity of Pre-treatment 18F-FDG PET/CT for Predicting the Extranodular Spread of Lymph Node Metastases in Patients with Oral Squamous Cell Carcinoma.
    Fukuhara R; Shinya T; Fukuma S; Ogawa N; Masaoka Y; Tanaka T; Marunaka H; Arioka T; Hiraki T; Kaji M; Kanazawa S
    Acta Med Okayama; 2020 Apr; 74(2):123-128. PubMed ID: 32341586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    Am J Otolaryngol; 2019; 40(2):297-305. PubMed ID: 30473166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [
    Linz C; Brands RC; Kertels O; Dierks A; Brumberg J; Gerhard-Hartmann E; Hartmann S; Schirbel A; Serfling S; Zhi Y; Buck AK; Kübler A; Hohm J; Lapa C; Kircher M
    Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3951-3960. PubMed ID: 34050405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of PET-CT in detecting nodal metastasis in cN0 early stage oral cavity squamous cell carcinoma.
    Zhang H; Seikaly H; Biron VL; Jeffery CC
    Oral Oncol; 2018 May; 80():89-92. PubMed ID: 29706193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.
    Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim CS; Kim MS
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1685-91. PubMed ID: 23949547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic performance of
    Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
    Sohn B; Koh YW; Kang WJ; Lee JH; Shin NY; Kim J
    Acta Radiol; 2016 Nov; 57(11):1352-1359. PubMed ID: 26013025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
    Slevin F; Subesinghe M; Ramasamy S; Sen M; Scarsbrook AF; Prestwich RJ
    Br J Radiol; 2015 Aug; 88(1052):20140592. PubMed ID: 26081447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
    Fischbein NJ; AAssar OS; Caputo GR; Kaplan MJ; Singer MI; Price DC; Dillon WP; Hawkins RA
    AJNR Am J Neuroradiol; 1998 Aug; 19(7):1189-96. PubMed ID: 9726451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
    Tapia M; Manji J; Dhillon K; Kleid S; Flatman S; Prasad J; Cardin A; Fua T; Rischin D; Dixon B; J R Magarey M
    Oral Oncol; 2022 Dec; 135():106213. PubMed ID: 36274346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved detection of metastatic lymph nodes in oesophageal squamous cell carcinoma by combined interpretation of fluorine-18-fluorodeoxyglucose positron-emission tomography/computed tomography.
    Lee JY; Kim YH; Park YJ; Park SB; Chung HW; Zo JI; Shim YM; Lee KS; Choi JY
    Cancer Imaging; 2019 Jun; 19(1):40. PubMed ID: 31227017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.
    Kyzas PA; Evangelou E; Denaxa-Kyza D; Ioannidis JP
    J Natl Cancer Inst; 2008 May; 100(10):712-20. PubMed ID: 18477804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.
    Burian E; Palla B; Callahan N; Pyka T; Wolff C; von Schacky CE; Schmid A; Froelich MF; Rübenthaler J; Makowski MR; Gassert FG
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3870-3877. PubMed ID: 35606526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation analysis between the SUVmax of FDG-PET/CT and clinicopathological characteristics in oral squamous cell carcinoma.
    Zheng D; Niu L; Liu W; Zheng C; Yan R; Gong L; Dong Z; Li K; Fei J
    Dentomaxillofac Radiol; 2019 Jul; 48(5):20180416. PubMed ID: 30794427
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Bae MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):237-244. PubMed ID: 31606761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma.
    Hong CM; Park SH; Chong GO; Lee YH; Jeong JH; Lee SW; Lee J; Ahn BC; Jeong SY
    Cancer Imaging; 2019 Jun; 19(1):43. PubMed ID: 31234933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of sentinel lymph node scintigraphy and intraoperative gamma probing with gold standard elective neck dissection in patients with N0 oral squamous cell cancers.
    Sundaram PS; Subramanyam P
    Nucl Med Commun; 2019 Nov; 40(11):1138-1147. PubMed ID: 31568193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.